We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

WilmerHale, Cooley Guide $100M Biotech IPOs

Law360 (September 14, 2018, 7:08 PM EDT) -- Cooley LLP-guided immuno-oncology firm Allogene Therapeutics on Friday unveiled a $100 million initial public offering in a bid to push ahead with its allogeneic T cell cancer therapies, while fellow biopharmaceutical...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.